Home » Topics » BioWorld

BioWorld
RSS

BTG'S BIOTROPIN ENTERS PHASE I TRIALS

Oct. 7, 1991

GENZYME PLACES $100M IN NOTES

Oct. 7, 1991

CARRINGTON TRADES ON AMERICAN EXCHANGE

Oct. 7, 1991

AGOURON FILES FOR 2 MILLION-SHARE OFFERING

Oct. 7, 1991

POTENTIAL 'BLOCKBUSTER' FOR LTIZ

Oct. 7, 1991

ICOS TO CO-DEVELOP DRUGS WITH GLAXO

Oct. 7, 1991

CEL-SCI COMPLETES PRIVATE PLACEMENT

Oct. 7, 1991

ALFACELL EXPANDS ONCONASE TRIALS

Oct. 7, 1991

ONCOSCINT APPROVED IN GERMANY

Oct. 4, 1991

MIXED SIGNALS ON CENTOXIN PROSPECTS

Oct. 4, 1991

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...